PortfoliosLab logoPortfoliosLab logo
RGC vs. BWXT
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

RGC vs. BWXT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Regencell Bioscience Holdings Limited (RGC) and BWX Technologies, Inc. (BWXT). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, RGC achieves a 13.10% return, which is significantly higher than BWXT's 7.16% return.


RGC

1D
2.59%
1M
-13.19%
YTD
13.10%
6M
82.55%
1Y
48.17%
3Y*
242.31%
5Y*
10Y*

BWXT

1D
-1.36%
1M
-14.64%
YTD
7.16%
6M
6.02%
1Y
44.72%
3Y*
44.37%
5Y*
25.04%
10Y*
19.18%
*Multi-year figures are annualized to reflect compound growth (CAGR)

RGC vs. BWXT - Yearly Performance Comparison


2026 (YTD)20252024202320222021
RGC
Regencell Bioscience Holdings Limited
13.10%16,053.85%-52.95%-62.35%-12.43%203.33%
BWXT
BWX Technologies, Inc.
7.16%56.37%46.53%33.87%23.30%-15.59%

Correlation

The correlation between RGC and BWXT is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.16

Correlation (3Y)
Calculated over the trailing 3-year period

0.04

Correlation (All Time)
Calculated using the full available price history since Jul 19, 2021

0.06

The correlation between RGC and BWXT shifts across timeframes, from 0.04 (3 years) to 0.16 (1 year), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

RGC:

$11.74B

BWXT:

$16.98B

EPS

RGC:

-$0.02

BWXT:

$3.75

PB Ratio

RGC:

9.63K

BWXT:

13.26

Total Revenue (TTM)

RGC:

$0.00

BWXT:

$3.38B

Gross Profit (TTM)

RGC:

-$40.84K

BWXT:

$566.27M

EBITDA (TTM)

RGC:

-$8.81M

BWXT:

$534.48M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

RGC vs. BWXT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RGC
RGC Risk / Return Rank: 6565
Overall Rank
RGC Sharpe Ratio Rank: 4545
Sharpe Ratio Rank
RGC Sortino Ratio Rank: 9191
Sortino Ratio Rank
RGC Omega Ratio Rank: 9090
Omega Ratio Rank
RGC Calmar Ratio Rank: 5353
Calmar Ratio Rank
RGC Martin Ratio Rank: 4747
Martin Ratio Rank

BWXT
BWXT Risk / Return Rank: 7070
Overall Rank
BWXT Sharpe Ratio Rank: 7171
Sharpe Ratio Rank
BWXT Sortino Ratio Rank: 6767
Sortino Ratio Rank
BWXT Omega Ratio Rank: 6767
Omega Ratio Rank
BWXT Calmar Ratio Rank: 7474
Calmar Ratio Rank
BWXT Martin Ratio Rank: 7373
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RGC vs. BWXT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Regencell Bioscience Holdings Limited (RGC) and BWX Technologies, Inc. (BWXT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


RGCBWXTDifference
Sharpe ratioReturn per unit of total volatility

-0.87

Sortino ratioReturn per unit of downside risk

+1.83

Omega ratioGain probability vs. loss probability

1.44

1.21

+0.22

Calmar ratioReturn relative to maximum drawdown

0.56

2.00

-1.45

Martin ratioReturn relative to average drawdown

0.67

4.66

-3.99

RGC vs. BWXT - Sharpe Ratio Comparison

The current RGC Sharpe Ratio is 0.14, which is lower than the BWXT Sharpe Ratio of 1.01. The chart below compares the historical Sharpe Ratios of RGC and BWXT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


RGCBWXTDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.14

1.01

-0.87

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.77

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.63

Sharpe Ratio (All Time)

Calculated using the full available price history

0.49

0.60

-0.11

Drawdowns

RGC vs. BWXT - Drawdown Comparison

The maximum RGC drawdown since its inception was -93.09%, which is greater than BWXT's maximum drawdown of -47.88%. Use the drawdown chart below to compare losses from any high point for RGC and BWXT.


Loading charts...

Drawdown Indicators


RGCBWXTDifference

Max Drawdown

Largest peak-to-trough decline

-93.09%

-47.88%

-45.21%

Max Drawdown (1Y)

Largest decline over 1 year

-86.72%

-22.42%

-64.30%

Max Drawdown (3Y)

Largest decline over 3 years

-88.34%

-32.87%

-55.47%

Max Drawdown (5Y)

Largest decline over 5 years

-32.92%

Max Drawdown (10Y)

Largest decline over 10 years

-47.74%

Current Drawdown

Current decline from peak

-69.55%

-22.42%

-47.13%

Average Drawdown

Average peak-to-trough decline

-59.29%

-13.16%

-46.13%

Ulcer Index

Depth and duration of drawdowns from previous peaks

71.76%

9.62%

+62.14%

Volatility

RGC vs. BWXT - Volatility Comparison

Regencell Bioscience Holdings Limited (RGC) has a higher volatility of 21.55% compared to BWX Technologies, Inc. (BWXT) at 10.63%. This indicates that RGC's price experiences larger fluctuations and is considered to be riskier than BWXT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


RGCBWXTDifference

Volatility (1M)

Calculated over the trailing 1-month period

21.55%

10.63%

+10.92%

Volatility (6M)

Calculated over the trailing 6-month period

110.23%

33.34%

+76.89%

Volatility (1Y)

Calculated over the trailing 1-year period

344.85%

44.54%

+300.31%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

308.92%

32.85%

+276.07%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

308.92%

30.74%

+278.18%

Dividends

RGC vs. BWXT - Dividend Comparison

RGC has not paid dividends to shareholders, while BWXT's dividend yield for the trailing twelve months is around 0.56%.


PositionTTM20252024202320222021202020192018201720162015
BWXT
BWX Technologies, Inc.
0.56%0.58%0.86%1.20%1.52%1.75%1.26%1.10%1.67%0.69%0.91%30.37%
RGC
Regencell Bioscience Holdings Limited
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

RGC vs. BWXT - Financials Comparison

This section allows you to compare key financial metrics between Regencell Bioscience Holdings Limited and BWX Technologies, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


-2.50B-2.00B-1.50B-1.00B-500.00M0.00500.00M1.00B2021202220232024202520260
860.22M
(RGC) Total Revenue
(BWXT) Total Revenue
Values in USD except per share items

Frequently Asked Questions


RGC and BWXT have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

RGC has higher volatility (21.55%) compared to BWXT (10.63%). In terms of maximum drawdown, RGC dropped -93.09% vs BWXT's -47.88%.

BWXT currently has the higher Sharpe Ratio (1.01 vs 0.14), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for RGC and BWXT

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer